These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 27548066)

  • 1. IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release.
    Siede J; Fröhlich A; Datsi A; Hegazy AN; Varga DV; Holecska V; Saito H; Nakae S; Löhning M
    PLoS One; 2016; 11(8):e0161507. PubMed ID: 27548066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.
    Matta BM; Reichenbach DK; Zhang X; Mathews L; Koehn BH; Dwyer GK; Lott JM; Uhl FM; Pfeifer D; Feser CJ; Smith MJ; Liu Q; Zeiser R; Blazar BR; Turnquist HR
    Blood; 2016 Jul; 128(3):427-39. PubMed ID: 27222477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
    Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.
    Wen YH; Lin HQ; Li H; Zhao Y; Lui VWY; Chen L; Wu XM; Sun W; Wen WP
    Cancer Immunol Immunother; 2019 Feb; 68(2):221-232. PubMed ID: 30357458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33 in T Cell Differentiation, Function, and Immune Homeostasis.
    Peine M; Marek RM; Löhning M
    Trends Immunol; 2016 May; 37(5):321-333. PubMed ID: 27055914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
    Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
    Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P
    Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-33-ST2-MyD88 axis promotes regulatory T cell proliferation in the murine liver.
    Xu L; Li W; Wang X; Zhang L; Qi Q; Dong L; Wei C; Pu Y; Li Y; Zhu J; Zhou S; Liu F; Chen X; Su C
    Eur J Immunol; 2018 Aug; 48(8):1302-1307. PubMed ID: 29729112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ST2
    Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K
    Front Immunol; 2024; 15():1351405. PubMed ID: 38571949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33 Reverses an Obesity-Induced Deficit in Visceral Adipose Tissue ST2+ T Regulatory Cells and Ameliorates Adipose Tissue Inflammation and Insulin Resistance.
    Han JM; Wu D; Denroche HC; Yao Y; Verchere CB; Levings MK
    J Immunol; 2015 May; 194(10):4777-83. PubMed ID: 25870243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.
    Turnquist HR; Zhao Z; Rosborough BR; Liu Q; Castellaneta A; Isse K; Wang Z; Lang M; Stolz DB; Zheng XX; Demetris AJ; Liew FY; Wood KJ; Thomson AW
    J Immunol; 2011 Nov; 187(9):4598-610. PubMed ID: 21949025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8
    Chen H; Chen Y; Liu H; Que Y; Zhang X; Zheng F
    Front Immunol; 2018; 9():1179. PubMed ID: 29896199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cell is critical for interleukin-33-mediated neuroprotection against stroke.
    Liu X; Hu R; Pei L; Si P; Wang C; Tian X; Wang X; Liu H; Wang B; Xia Z; Xu Y; Song B
    Exp Neurol; 2020 Jun; 328():113233. PubMed ID: 32044328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.
    Cottagiri M; Nyandjo M; Stephens M; Mantilla JJ; Saito H; Mackay IR; Rose NR; Njoku DB
    Cell Mol Immunol; 2019 Aug; 16(8):706-717. PubMed ID: 30030493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells.
    Matta BM; Lott JM; Mathews LR; Liu Q; Rosborough BR; Blazar BR; Turnquist HR
    J Immunol; 2014 Oct; 193(8):4010-20. PubMed ID: 25217167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells.
    Li Y; Guan X; Liu W; Chen HL; Truscott J; Beyatli S; Metwali A; Weiner GJ; Zavazava N; Blumberg RS; Urban JF; Blazar BR; Elliott DE; Ince MN
    J Immunol; 2018 Nov; 201(10):2910-2922. PubMed ID: 30291167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate Control of Tissue-Reparative Human Regulatory T Cells.
    Lam AJ; MacDonald KN; Pesenacker AM; Juvet SC; Morishita KA; Bressler B; ; Pan JG; Sidhu SS; Rioux JD; Levings MK
    J Immunol; 2019 Apr; 202(8):2195-2209. PubMed ID: 30850479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons.
    He Z; Song J; Hua J; Yang M; Ma Y; Yu T; Feng J; Liu B; Wang X; Li Y; Li J
    Cell Death Dis; 2018 Dec; 9(12):1173. PubMed ID: 30518915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.